You are here: Home » Markets » News
Business Standard

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

TCS hit a new high of Rs 1,849 per share on the BSE intra-day, after the IT major said that its board has approved a proposal of buyback upto 76.19 million equity shares at price of Rs 2,100 per share

Topics
Market Wrap  |  Nifty  |  Sensex

SI Reporter  |  New Delhi 

The markets trimmed their day's losses and ended flat on Friday amid weakness in their Asian peers, that wobbled on Friday as investors braced for US tariffs against China. The S&P BSE Sensex ended at 35,622, up 22 points while the broader Nifty50 index settled at 10,818, up 10 points. Among sectoral indices, the Nifty Pharma index ended over 2% higher led by rise in the shares of Dr. Reddy's Laboratories, Cipla and Piramal Enterprises. The Nifty IT index too settled over 2% led by a rally in Infosys and Tata Consultancy Services ...

MONTHLY STAR

Business Standard Digital

Business Standard Digital Monthly Subscription
149.00  
subscribe
Complete access to the premium product
Convenient - Pay as you go
Pay using Master/Visa Credit Card & ICICI VISA Debit Card
Auto renewed (subject to your card issuer's permission)
Cancel any time in the future
Requires personal information

What you get?

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all the content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

NOTE :

  • The product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the email with the cancellation request to assist@bsmail.in. Include your contact number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART MONTHLY

Business Standard Digital

Business Standard Digital - 12 Months
1499.00
subscribe
Get 12 months of Business Standard digital access
Single Seamless Sign-up to Business Standard Digital
Convenient - Once a year payment
Pay using an instrument of your choice - Credit/Debit Cards, Net Banking, Payment Wallets accepted
Exclusive Invite to select Business Standard events

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.

NOTE :

  • This product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

MARKET COMMENT Jayant Manglik, President, Religare Broking In yet another volatile trading session, the Indian equity benchmark indices ended Friday’s session on the flat note. Throughout the day, markets remained range bound and the Nifty index swung both ways touching intra-day high of 10,834 in first half and intra-day low of 10,755 in second half and finally ended flat at 10,818 levels. BSE Midcap & Smallcap, underperformed the benchmark, to close with losses of 0.4% and 0.5%, respectively. Barring Healthcare and IT, which closed nearly 2% higher, selling pressure was witnessed among all the other sectorial indices.Capital Goods, Metals, Oil & Gas and Power remained the top losers. Amongst the global indices, both European and Asian markets traded on a mixed note.   We continue to remain cautious on the markets in the coming sessions. With lack of any fresh positive domestic triggers in the near term, volatility is likely to remain high with stock specific movement. Market participants will closely monitor global developments, especially in US, Europe and China. Any further correction should be considered as a good buying opportunity for investors in quality counters

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Nifty IT index settled 2.14% higher. Top gainers: COMPANY LATEST PREV CLOSE GAIN() GAIN(%) INFOSYS 1281.65 1239.70 41.95 3.38 ORACLE FIN.SERV. 4140.00 4008.70 131.30 3.28 TCS 1844.90 1787.55 57.35 3.21 TECH MAHINDRA 709.60 698.80 10.80 1.55 MINDTREE 1003.15 992.75 10.40 1.05

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Nifty Pharma index ended 2.24% higher. Top gainers: COMPANY LATEST PREV CLOSE GAIN() GAIN(%) CIPLA 612.00 588.05 23.95 4.07 DR REDDY'S LABS 2351.45 2269.40 82.05 3.62 PIRAMAL ENTERP. 2501.00 2427.40 73.60 3.03 SUN PHARMA.INDS. 572.00 559.25 12.75 2.28 BIOCON 625.30 614.35 10.95 1.78

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Nifty sectoral gainers and losers of the day

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

BSE Sensex: Dr. Reddy's, Infosys, TCS among top gainers of the day. ONGC top loser.

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Market at close   The S&P BSE Sensex ended at 35,622, up 22 points while the broader Nifty50 index settled at 10,818, up 10 points.

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

TCS hits new high as board approves share buyback at Rs 2100 per share Shares of Tata Consultancy Services (TCS) hit a new high of Rs 1,849 per share, up 3% on the BSE after the company said its board approved a proposal of buyback upto 76.19 million equity shares at price of Rs 2,100 per share through tender offer. The stock surpassed its previous high of Rs 1,840 recorded on June 14, 2018. READ MORE  

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Tech start-up listing: NSE considers tweaking SME platform The National Stock Exchange (NSE) is considering tweaking its Emerge platform, essentially meant for small-and medium-sized enterprises (SMEs), to facilitate the listing of technology (IT)start-ups.   According to Vikram Limaye, chief executive officer at the NSE, technology start-ups have their own set of requirements and attract a particular set of investors, which is the primary reason Emerge needs some changes to accommodate their needs. READ MORE

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Manpasand Beverages put under ASM framework; stock falls 5%   Manpasand Beverages was locked in lower circuit of 5% at Rs 158 on the BSE after the exchange placed shares of the company under ASM (Additional Surveillance Measure) framework effective from today, June 15, 2018.   The BSE shifted Manpasand Beverages and Sai Baba Investment and Commercial Enterprises under enhanced surveillance measures where 100% margins will be applicable from June 16, 2018. READ MORE

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Millionaires now control half of the world's personal wealth: Report The rich are getting a lot richer and doing so a lot faster. Personal wealth around the globe reached $201.9 trillion last year, a 12 per cent gain from 2016 and the strongest annual pace in the past five years, Boston Consulting Group said in a report released Thursday. Booming equity markets swelled fortunes, and investors outside the U. S. got an exchange-rate bonus as most major currencies strengthened against the greenback. READ MORE

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

Why yen investors are worried about a future SoftBank without Masayoshi Son Masayoshi Son is fond of talking about his 300-year vision for SoftBank Group Corp. but some Japanese bond investors are already pondering an earlier event -- what will the technology giant be like without its founder? READ MORE

First Published: Fri, June 15 2018. 15:30 IST
RECOMMENDED FOR YOU

MARKET WRAP: Indices trim losses to end flat, Nifty at 10,818; Pharma gains

TCS hit a new high of Rs 1,849 per share on the BSE intra-day, after the IT major said that its board has approved a proposal of buyback upto 76.19 million equity shares at price of Rs 2,100 per share

The markets trimmed their day's losses and ended flat on Friday amid weakness in their Asian peers, that wobbled on Friday as investors braced for US tariffs against China. The S&P BSE Sensex ended at 35,622, up 22 points while the broader Nifty50 index settled at 10,818, up 10 points. Among sectoral indices, the Nifty Pharma index ended over 2% higher led by rise in the shares of Dr. Reddy's Laboratories, Cipla and Piramal Enterprises. The Nifty IT index too settled over 2% led by a rally in Infosys and Tata Consultancy Services ...

image
Business Standard
177 22
.